HomeCATX • NYSEAMERICAN
add
Perspective Therapeutics Inc
Nakaraang pagsara
$3.28
Sakop ng araw
$3.16 - $3.41
Sakop ng taon
$1.60 - $16.55
Market cap
239.02M USD
Average na Volume
1.17M
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 342.00K | 5.23% |
Gastos sa pagpapatakbo | 8.74M | 42.31% |
Net na kita | -18.18M | -47.97% |
Net profit margin | -5.31K | -40.62% |
Kita sa bawat share | -0.25 | — |
EBITDA | -21.10M | -66.81% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 211.70M | 17.19% |
Kabuuang asset | 329.35M | 18.35% |
Kabuuang sagutin | 44.70M | -7.63% |
Kabuuang equity | 284.64M | — |
Natitirang share | 74.23M | — |
Presyo para makapag-book | 0.85 | — |
Return on assets | -16.28% | — |
Return on capital | -18.72% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -18.18M | -47.97% |
Cash mula sa mga operasyon | -21.58M | -255.85% |
Cash mula sa pag-invest | -5.56M | 88.23% |
Cash mula sa financing | 9.97M | -94.00% |
Net change in cash | -17.17M | -112.92% |
Malayang cash flow | -20.92M | -19.98% |
Tungkol
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu.
The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
Itinatag
2004
Headquarters
Website
Mga Empleyado
138
